Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
NCT04426253 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-06-11
Summary
The study aims to identify environmental factors and genetic (gene mutation and gene expression) changes, which influencing the course of the disease the new type of coronavirus infection COVID-19 in patients nationwide in a multicenter study.
At first in the study will be performed 200 patients, selected for a homogeneous groups on the basis of the patient's anamnestic data, genetic testing.
Following the interim analysis, based on the results, another 800 people are planned to involve.
Conditions
- COVID-19
- Sars-CoV2
Sponsors & Collaborators
-
Szeged University
lead OTHER
Principal Investigators
-
Márta Széll, MD, Ph.D. · University of Szeged, Department of Medical Genetics
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-05
- Primary Completion
- 2020-12-31
- Completion
- 2021-07-31
Countries
- Hungary
Study Locations
More Related Trials
-
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
NCT00953667 ·Status: COMPLETED ·Phase: NA
-
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
NCT00597090 ·Status: COMPLETED
-
Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
NCT01375543 ·Status: COMPLETED
-
The Fondazione Genomic SARS-CoV-2 Study COVID-19
NCT06549712 ·Status: COMPLETED ·Phase: NA
-
Genetic Bases of COVID-19 Clinical Variability
NCT04549831 ·Status: RECRUITING
-
Study of Clinical and Molecular Manifestations of Genetic Disorders
NCT00001466 ·Status: COMPLETED
-
Impact of the Genetic Polymorphism on COVID-19 in Egypt
NCT05157217 ·Status: UNKNOWN
-
Omics Gaucher Study: Multiomic Approach
NCT05526664 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD
NCT04494360 ·Status: COMPLETED
-
Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum
NCT04889014 ·Status: COMPLETED ·Phase: NA
-
Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality
NCT02380729 ·Status: COMPLETED
-
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders
NCT04399694 ·Status: COMPLETED
-
Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations
NCT02789527 ·Status: COMPLETED ·Phase: NA
-
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825 ·Status: RECRUITING
-
Pharmacogenetic Testing in Primary Care
NCT01600846 ·Status: COMPLETED
-
Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway
NCT03799705 ·Status: COMPLETED
-
Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function
NCT04506229 ·Status: UNKNOWN
-
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
NCT02780531 ·Status: COMPLETED
-
Pharmacogenetic Testing for Medication Management.
NCT02559193 ·Status: WITHDRAWN
-
Pharmacogenetic Testing and Chronic Pain
NCT05259865 ·Status: SUSPENDED
-
A Study to Compare Genetic Variations of IGF-I and IGF-II
NCT01329523 ·Status: COMPLETED
-
Genetics of Hepatitis C Virus Infection
NCT00005657 ·Status: COMPLETED
-
Clinical Trial of the Sequence of Cardiovascular Genetic Counseling and Testing
NCT05422573 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Adult Patients With Undiagnosed Conditions and Their Responses to Clinically Uncertain Results From Exome Sequencing
NCT03605004 ·Status: COMPLETED
-
Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients
NCT04630093 ·Status: COMPLETED ·Phase: NA